Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03450499
Other study ID # IRC/1089/017
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date April 1, 2018
Est. completion date March 7, 2019

Study information

Verified date August 2019
Source B.P. Koirala Institute of Health Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomized double blind study will be conducted in pregnant woman planned for non elective cesarean section under spinal anesthesia. Ketamine group will receive intravenous 0.25 mg/kg and placebo group will receive same amount of normal saline after spinal anesthesia prior to skin incision. Postoperative outcomes measures are total opioid consumption and pain scores for 24 hrs.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date March 7, 2019
Est. primary completion date March 7, 2019
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- • All women at term(>or =37 weeks of gestation)

- Healthy

- American Society of Anesthesiologists(ASA) class1 and 2

- Women undergoing non-elective caesarean section whose anesthetic plan is for spinal anesthesia with bupivacaine and fentanyl

Exclusion Criteria:

- • Women with American society of anesthesiologist physical status>2

- Body mass index >or =40 kg per square meter

- Height <150 cm

- Any contraindication to the spinal anesthesia

- History of substance abuse

- History of hallucinations

- Chronic opioid therapy

- Chronic pain or on any pain medication currently

- Patient with maternal complications,like cardiovascular disease pre-eclampsia,diabetes,multiple gestation,known fetal abnormality

- Cases with severely compromised fetus where immediate administration of general anesthesia is required.

Study Design


Related Conditions & MeSH terms

  • Non Elective Cesarean Section and Ketamine Analgesia

Intervention

Drug:
Ketamine
the analgesic affects of ketamine will be compared between the experimental and placebo group.
Placebo
the analgesic requirement will be calculated in placebo group.

Locations

Country Name City State
Nepal BP Koirala Institute of Health Sciences (BPKIHS) Dharan Bazar Koshi

Sponsors (1)

Lead Sponsor Collaborator
B.P. Koirala Institute of Health Sciences

Country where clinical trial is conducted

Nepal, 

Outcome

Type Measure Description Time frame Safety issue
Primary Total opioid requirement postoperatively Total opioid required up to 24 postoperatively in ketamine and placebo group. 24 hrs
Secondary Postoperative numerator rating scores(NRS)up to 24 hrs . postoperative ) • Postoperative NRS Scores (on arrival to Post operative care unit), 2, 4, 6, 8, 12 and 24 h ).The NRS ranges from 0- 10 and 0 refers to no pain and 10 means extreme possible pain perceived. 24 hrs
Secondary Time to first perception of pain Time to first perception of pain 24 hrs
Secondary Incidence of side effects Incidence of post operative nausea and vomiting, shivering, sedation scores, side effects related to ketamine during the first 24h 24 hrs